KR840002235B1 - Process for preparing carboxylic acid derivatives - Google Patents

Process for preparing carboxylic acid derivatives Download PDF

Info

Publication number
KR840002235B1
KR840002235B1 KR1019840004152A KR840004152A KR840002235B1 KR 840002235 B1 KR840002235 B1 KR 840002235B1 KR 1019840004152 A KR1019840004152 A KR 1019840004152A KR 840004152 A KR840004152 A KR 840004152A KR 840002235 B1 KR840002235 B1 KR 840002235B1
Authority
KR
South Korea
Prior art keywords
group
benzoic acid
theory
melting point
carbon atoms
Prior art date
Application number
KR1019840004152A
Other languages
Korean (ko)
Inventor
그리스 게르하르트
사우터 로베르트
그렐 볼프강
허나우스 루돌프
루프레흐트 에크하르트
카우비쉬 니콜라스
켈팅 요아힘
아이젤 베른하르트
파이퍼 헬무트
놀 클라우스
Original Assignee
닥터 칼 토매 지. 엠. 비. 에이치
프리쯔 좀머, 권터 엥겔하르트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1019800002788A external-priority patent/KR840002234B1/en
Application filed by 닥터 칼 토매 지. 엠. 비. 에이치, 프리쯔 좀머, 권터 엥겔하르트 filed Critical 닥터 칼 토매 지. 엠. 비. 에이치
Priority to KR1019840004152A priority Critical patent/KR840002235B1/en
Application granted granted Critical
Publication of KR840002235B1 publication Critical patent/KR840002235B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

2-Amino benzoic acid derivative(I) and its salts are prepared from cpmpd.(II) by means of conversion of diazonium salt with sulfuric acid or copper, where R5 = F, Cl, Br, cyano, or hydroxy gp.; R6,R7 = N-alkyl-cyclohexyl amino gp., N-alkylphenyl amino, Nalkyl-benzyl amino, C6-C12 cyclic alkylene amino, C1-C4 alkyl, C1-C3 alkoxy, piperydino, morpholine, thiomorpholino, piperazino, aza-bicycloalkyl, C6-C9 1,4-dioxa-8-aza-spiro-alkane, pyrolidino, or tetrahydro- pyridino gp.; and W = carboxy, aminocarbonyl, cyano, or C2-C4 alkoxy carbonyl.

Description

2-아미노-벤조산 유도체의 제조방법Method for preparing 2-amino-benzoic acid derivative

본 발명은 다음 일반식(I)의 신규 2-아미노-벤조산 유도체 및 이의 유기산 또는 무기산, 만일 W가 카복시 그룹이면, 염기와의 염의 제조방법에 관한 것으로 신규 2-아미노-벤조산 유도체의 약제 및/또는 제조 중간체로써의 용도도 포함한다.The present invention relates to a process for the preparation of a novel 2-amino-benzoic acid derivative of the general formula (I) and an organic or inorganic acid thereof, and, if W is a carboxy group, a salt with a base, wherein the agent of the novel 2-amino-benzoic acid derivative and // Or use as a manufacturing intermediate.

Figure kpo00001
Figure kpo00001

일반식(I)의 신규 화합물은 약리적 특징을 보이는데, 즉 중간대사에 영향을 미친다. 따라서 일반식(I)화합물은 지방저하 활성을 갖는다.The new compounds of formula (I) show pharmacological properties, ie affect intermediate metabolism. Therefore, general formula (I) compound has a fat lowering activity.

상기식에서, R5는 불소, 염소 또는 브롬, 시아노 또는 하이드록시그룹을 나타내며,Wherein R 5 represents fluorine, chlorine or bromine, cyano or hydroxy group,

R6및 R7은 이들이 부착된 질소와 함께 알킬이 탄소수 2 내지 4인 N-알킬-사이클로헥실아미노그룹, 알킬의 탄소수 1 내지 3인 N-알킬-페닐아미노 또는 N-알킬-벤질아미노그룹, 이미노환이 탄소수 6 내지 12인 비측쇄 알킬렌이미노그룹, 탄소수 1 내지 4의 알킬그룹, 탄소수 1 내지 3의 알콕시그룹, 탄소수 2내지 4의 알콕시카보닐그룹 또는 페닐그룹으로 치환된 피페리디노그룹, 탄소수 1 내지 3의 알킬그룹, 둘, 셋 또는 넷으로 치환된 피페리디노그룹, 탄소수 1 내지 3의 알킬그룹 하나 또는 둘로 임의 치환된 모르폴리노 또는 티오모르플리노그룹, 탄소수 1 내지 3의 알킬그룹, 총 탄소수 2 내지 4의 알콕시카보닐그룹, 페닐, 할로겐페닐, 피리딜, 벤질 또는 푸로일그룹으로 4위치가 치환된 피페라지노그룹, 탄소수 7 내지 10의 포화되거나 부분적으로 불포화된 아자-비사이클로알킬그룹, 탄소수 6 내지 9의 1, 4-디옥사-8-아자-스피로-알칸그룹, 피롤리디노 또는 테트라하이드로-피리디노그룹이며,R 6 and R 7 together with the nitrogen to which they are attached N-alkyl-cyclohexylamino group having 2 to 4 alkyl alkyl, N-alkyl-phenylamino or N-alkyl-benzylamino group having 1 to 3 carbon atoms of alkyl, Piperidino substituted with unbranched alkyleneimino group having 6 to 12 carbon atoms, alkyl group having 1 to 4 carbon atoms, alkoxy group having 1 to 3 carbon atoms, alkoxycarbonyl group having 2 to 4 carbon atoms or phenyl group A group, an alkyl group having 1 to 3 carbon atoms, a piperidino group substituted with two, three or four, a morpholino or thiomorphlino group optionally substituted with one or two alkyl groups having 1 to 3 carbon atoms, 1 to 3 carbon atoms An alkyl group of 2 to 4 carbon atoms, alkoxycarbonyl group of 2 to 4 carbon atoms, phenyl, halogenphenyl, pyridyl, benzyl or furoyl group substituted with a piperazino group, saturated or partially unsaturated of 7 to 10 carbon atoms Keep it up -A bicycloalkyl group, a C6-C9 1, 4-dioxa-8-aza-spiro-alkane group, a pyrrolidino or a tetrahydro-pyridino group,

W는 각각 탄소수 2 내지 4의 카복시, 아미노카보닐, 시아노 또는 알콕시카보닐이다.W is carboxy, aminocarbonyl, cyano or alkoxycarbonyl having 2 to 4 carbon atoms, respectively.

따라서 R5내지 R7, W를 정의하는데 언급한 가운데에는 다음이 포함된다.Thus, among the references to defining R 5 to R 7 , W includes:

R5는 불소, 염소 또는 불소, 시아노, 하이드록시그룹이며,R 5 is fluorine, chlorine or fluorine, cyano, hydroxy group,

R6및 R7은 이들이 부착된 질소와 함께 N-메틸-페닐아미노, N-에틸-페닐아미노, N-이소프로필-페닐아미노, N-메틸-벤질아미노, N-에틸-벤질-아미노, N-프로필-벤질아미노, N-에틸-사이클로헥실아미노, N-프로필-사이클로헥실아미노, N-이소프로필-사이클로헥실아미노, N-부틸-사이클로헥실아미노, 피롤리디노, 헵사메틸렌이미노, 헵타메틸렌이미노, 옥타메틸렌이미노, 노나메틸렌이미노, 데카메틸렌이미노, 운데카메틸렌이미노, 도데카메틸렌이미노, 메틸-피레리디노, 에틸-피페리디노, 프로필-피페리디노, 이소프로필-피페리디노, 부틸-피페리디노, 이소부틸-피페리디노, 3급-부틸-피페리디노, 메톡시-피페리디노, 에톡시-피페리디노, 프로폭시-페피리디노, 이소프로폭시-피페리디노, 메톡시카보닐-피페리디노, 에톡시카보닐-피페리디노, 프로폭시카보닐-피페리디노, 이소프로폭시카보닐-피페리디노, 디메틸-피페리디노, 트리메틸-피페리디노, 테트라메틸-피페리디노, 디에틸-피페리디노, 디프로필-피페리디노, 테트라에틸-피페리디노, 메틸-에틸-피페리디노, 에틸-프로필-피페리디노, 모르폴리노, 메틸-모르폴리노, 에틸-모르폴리노, 프로필-모르폴리노, 디메틸-모르폴리노, 디에틸-모르폴리노, 티오모르폴리노, 메틸-티오모르폴리노, 프로필-티오모르폴리노, 디메틸-티오모르폴리노, N-메틸-피페라지노, N-에틸-피페라지노, N-프로필-피페라지노, N-메톡시카보닐-피페라지노, N-에톡시카보닐-피페라지노, N-이소-프로폭시카보닐-피페라지노, N-페닐-피페라지노, N-플루오로-페닐-피페라지노, N-클로로페닐-피페라지노, N-브로모페닐-피페라지노, N-피리딜-피페라지노, N-벤질-피페라지노, N-푸로일-피페라지노, 옥타하이드로-이소인돌-2-일, 테트라하이드로-이소퀴놀린-2-일, 옥타하이드로-이소퀴놀린-2-일, 데카하이드로-이소퀴놀린-2-일, 테트라하이드로-3-벤즈아제핀-3-일, 테카하이드로-3-벤즈아제핀-3-일, 3-아자-비사이클로-노난-3-일, 1,4, 디옥사-8-아자-스피로[4,5]데칸-8-일, 1,4-디옥사-8-아자-스피로[4,6]운데칸-8-일 또는 테트라하이드로-피리디노그룹이며,R 6 and R 7 together with the nitrogen to which they are attached N-methyl-phenylamino, N-ethyl-phenylamino, N-isopropyl-phenylamino, N-methyl-benzylamino, N-ethyl-benzyl-amino, N -Propyl-benzylamino, N-ethyl-cyclohexylamino, N-propyl-cyclohexylamino, N-isopropyl-cyclohexylamino, N-butyl-cyclohexylamino, pyrrolidino, hepsa methyleneimino, heptamethylene Imino, octamethyleneimino, nonamethyleneimino, decamethyleneimino, undecamethyleneimino, dodecamethyleneimino, methyl-pyrrididino, ethyl-piperidino, propyl-piperidino, isopropyl Piperidino, butyl-piperidino, isobutyl-piperidino, tert-butyl-piperidino, methoxy-piperidino, ethoxy-piperidino, propoxy-piperidino, isopro Foxy-piperidino, methoxycarbonyl-piperidino, ethoxycarbonyl-piperidino, propoxycarbonyl-pipe Lidino, Isopropoxycarbonyl-piperidino, dimethyl-piperidino, trimethyl-piperidino, tetramethyl-piperidino, diethyl-piperidino, dipropyl-piperidino, tetraethyl-pipe Ferridino, methyl-ethyl-piperidino, ethyl-propyl-piperidino, morpholino, methyl-morpholino, ethyl-morpholino, propyl-morpholino, dimethyl-morpholino, diethyl- Morpholino, thiomorpholino, methyl-thiomorpholino, propyl-thiomorpholino, dimethyl-thiomorpholino, N-methyl-piperazino, N-ethyl-piperazino, N-propyl- Piperazino, N-methoxycarbonyl-piperazino, N-ethoxycarbonyl-piperazino, N-iso-propoxycarbonyl-piperazino, N-phenyl-piperazino, N-fluor Rho-phenyl-piperazino, N-chlorophenyl-piperazino, N-bromophenyl-piperazino, N-pyridyl-piperazino, N-benzyl-piperazino, N-furoyl-pi Perrazino, Octa Idro-isoindol-2-yl, tetrahydro-isoquinolin-2-yl, octahydro-isoquinolin-2-yl, decahydro-isoquinolin-2-yl, tetrahydro-3-benzazin-3- Yl, tecahydro-3-benzazin-3-yl, 3-aza-bicyclo-nonan-3-yl, 1,4, dioxa-8-aza-spiro [4,5] decan-8-yl , 1,4-dioxa-8-aza-spiro [4,6] undecane-8-yl or tetrahydro-pyridino group,

W는 카복시, 아미노카보닐, 메톡시카보닐, 에톡시카보닐, 프로폭시카보닐 또는 시아노그룹이다.W is carboxy, aminocarbonyl, methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl or cyano group.

그러나 상기 일반식(I)의 바람직한 화합물은 R5는 염소, 브롤, 하이드록시, 시아노그룹이며,However, the preferred compound of formula (I) is that R 5 is chlorine, bromine, hydroxy, cyano group,

R6및 R7은 이들이 부착된 질소와 함께, 알킬이 탄소수 2 내지 4인 N-알킬-사이클로헥실아미노그룹, 이미노환이 탄소수 6 내지 12인 비측쇄 알킬렌이미노그룹, 탄소수 1 내지 4의 알킬그룹, 페닐, 메톡시 또는 에톡시-카보닐그룹으로 4-위치가 치환된 피페리디노그룹, 메틸 또는 에틸그룹으로 3- 및 5-위치가 치환된 피페리디노그룹, 메틸그룹으로 3- 및 5-위치가 사치환된 피페리디노그룹, 메틸, 벤질, 페닐, 클로로페닐, 피리딜-(2)-, 에톡시카보닐 또는 푸로일-(2)-그룹으로 4-위치가 치환된 피페리지노그룹, 메틸그룹 하나 또는 둘로 임의 치환된 모르폴리노 또는 티오모르폴리노그룹, 피롤리디노, 테트라하이드로-피리디노, N-메틸-페닐아미노, N-메틸-벤질아미노, 1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일, 1,4-디옥사-8-아자-스피로 [4,6] 운데칸-8-일, 3-아자-비사이클로-노난-3-일, 1,2,4,5,-테트라하이드로-3-벤즈 아제핀-3-일, 데카하이드로-3-벤즈아제핀-3-일, 1,2,3,4,-테트라하이드로-이소퀴놀린-2-일, 1,2,3,4,5,6,7,8-옥타하이드로-이소퀴놀린-2-일, 데카하이드로-이소퀴놀린-2-일 또는 옥타하이드로 이소인돌-2-일그룹이며, W는 카복시, 아미노카보닐, 메톡시카보닐 또는 시아노그룹인 화합물 및 그 염, 특히 R5가 벤젠환의 5-위치에 존재하는 경우가 바람직하다.R 6 and R 7 together with the nitrogen to which they are attached are N-alkyl-cyclohexylamino group having 2 to 4 carbon atoms, unbranched alkyleneimino group having 6 to 12 carbon atoms, and having 1 to 4 carbon atoms. Piperidino group substituted with 4-position by alkyl group, phenyl, methoxy or ethoxy-carbonyl group, 3- and 5-position substituted piperidino group by methyl or ethyl group, 3- by methyl group And 4-position substituted with a 5-positioned tetrasubstituted piperidino group, methyl, benzyl, phenyl, chlorophenyl, pyridyl- (2)-, ethoxycarbonyl or furoyl- (2) -group Piperizino group, morpholino or thiomorpholino group optionally substituted with one or two methyl groups, pyrrolidino, tetrahydro-pyridino, N-methyl-phenylamino, N-methyl-benzylamino, 1,4 -Dioxa-8-aza-spiro [4,5] decan-8-yl, 1,4-dioxa-8-aza-spiro [4,6] undecane-8-yl, 3-aza-bissai Rho-nonan-3-yl, 1,2,4,5, -tetrahydro-3-benz azepin-3-yl, decahydro-3-benzazin-3-yl, 1,2,3,4 , -Tetrahydro-isoquinolin-2-yl, 1,2,3,4,5,6,7,8-octahydro-isoquinolin-2-yl, decahydro-isoquinolin-2-yl or octahydro It is preferable that the compound is an isoindol-2-yl group and W is a carboxy, aminocarbonyl, methoxycarbonyl or cyano group, and a salt thereof, especially when R 5 is present at the 5-position of the benzene ring.

일반식(I)의 특히 바람직한 화합물은Particularly preferred compounds of formula (I) are

R5는 5-위치의 염소 또는 브롬이며R 5 is chlorine or bromine in the 5-position

R6및 R7은 이들이 부착된 질소와 함께 이미노환이 탄소수 6 내지 8인 비측쇄 알킬렌이미노그룹, 1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일, 1,4-디옥사-8-아자-스피로 [4,6] 운데칸-8-일, 데카하이드로-3H-3-벤즈아제핀-3-일 또는 4-메톡시-피페리디노그룹이며,R 6 and R 7 together with the nitrogen to which they are attached are non-branched alkyleneimino groups having 6 to 8 carbon atoms, 1,4-dioxa-8-aza-spiro [4,5] decane-8-yl , 1,4-dioxa-8-aza-spiro [4,6] undecane-8-yl, decahydro-3H-3-benzazin-3-yl or 4-methoxy-piperidino group ,

W는 카복시그룹인 화합물 및 이의 유기산 또는 무기산과의 생리적으로 무독한 산부가염 또는 W가 카복시그룹인 경우 염기와의 염이다.W is a physiologically toxic acid addition salt with a compound that is a carboxy group and its organic or inorganic acid, or a salt with a base when W is a carboxy group.

본 발명에 따라 신규화합물은 다음 방법으로 수득한다. 일반식(Ⅱ) 화합물과 나이트라이트를 반응시키고 수득된 디아조늄염을 임의로 구리 또는 상응하는 구리(I)염 존재하에 가열한다.According to the present invention a novel compound is obtained by the following method. The compound of formula (II) is reacted with nitrite and the diazonium salt obtained is optionally heated in the presence of copper or the corresponding copper (I) salt.

Figure kpo00002
Figure kpo00002

일반식(Ⅱ) 화합물을 물/염산, 메탄올/염산 또는 디옥산/염산 등의 적절한 용매 중에서 나트륨 나이트라이트 등의 나이트라이트 또는 아질산 에스테르로 -10 내지 5℃의 저온에서 디아조늄염으로 전환시킨다.The compound of formula (II) is converted into a diazonium salt at a low temperature of -10 to 5 ° C. with nitrite or nitrite ester such as sodium nitrite in a suitable solvent such as water / hydrochloric acid, methanol / hydrochloric acid or dioxane / hydrochloric acid.

수득된 상응하는 디아조늄염을 플루오로보레이트, 황산 중의 하이드로설페이트, 염화물로써의 구리 또는 염화구리(I)/염산, 브롬화구리(I)/브롬산 또는 삼나트륨-사시안화구리(I) 같은 상응하는 구리(I)염 존재하에 pH 7에서 15 내지 90℃로 가열하여 상응화합물로 전환시킨다.The corresponding diazonium salts obtained are the same as fluoroborate, hydrosulfate in sulfuric acid, copper or copper (I) / hydrochloric acid as chlorides, copper bromide (I) / bromic acid or trisodium-cyanide (I) It is heated to 15 to 90 ℃ in pH 7 in the presence of a copper (I) salt to convert to the corresponding compound.

본 발명에 따라 수득된 W가 시아노, 알콕시카보닐 또는 아미노카보닐그룹인 일반식(I) 화합물은 W가 카복시그룹인 일반식(I)의 상응화합물로 가수분해에 의해 전환시킬 수 있다.The compound of formula (I) wherein W is a cyano, alkoxycarbonyl or aminocarbonyl group obtained according to the invention can be converted by hydrolysis to the corresponding compound of formula (I) wherein W is a carboxy group.

가수분해는 메탄올, 에탄올, 디옥산, 물/에탄올 또는 물/테트라하이드로푸란 같은 수혼화성 용매 중에서 염산 또는 황산 같은 산 또는 수산화나트륨, 수산화칼륨 같은 염기 존재하에 반응물의 비점 등의 고온에서 바람직하게 이루어진다.Hydrolysis is preferably carried out at high temperatures such as boiling points of the reactants in the presence of acids such as hydrochloric acid or sulfuric acid or bases such as sodium hydroxide and potassium hydroxide in water miscible solvents such as methanol, ethanol, dioxane, water / ethanol or water / tetrahydrofuran.

또한 일반식(I)의 수득화합물은 만일 W가 카복시그룹을 나타내면 무기 또는 유기산 또는 염기에 의해 그의 생리적으로 무독한 염으로 전환시킬 수 있다. 적절한 산으로는 염산, 브롬화수소산, 황산, 인산, 락트산, 시트르산, 타타르산, 석신산, 말레산 또는 푸마르산이 있으며, 적절한 염기에는 수산화나트륨, 수산화칼륨 또는 사이클로헥실아민 등이 있다.The compounds obtained of formula (I) can also be converted to their physiologically toxic salts by inorganic or organic acids or bases if W represents a carboxy group. Suitable acids include hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, lactic acid, citric acid, tartaric acid, succinic acid, maleic acid or fumaric acid, and suitable bases include sodium hydroxide, potassium hydroxide or cyclohexylamine.

출발물질로 사용된 일반식(Ⅱ)의 화합물은 문헌에 알려져 있으며, 각각 기지의 방법에 따라 수득된다. 예를 들어 일반식(Ⅱ)의 화합물은 2-클로로- 또는 2-브로모-니트로 카복실산 또는 그 유도체와 상응하는 아민과 반응시키고, 수득된 2-아미노 화합물의 니트로그룹을 촉매 활성화수소, 발생기수소, 금속 또는 금속염에 의해 환원시켜 수득한다.Compounds of formula (II) used as starting materials are known in the literature and are each obtained according to known methods. For example, the compound of general formula (II) is reacted with 2-chloro- or 2-bromo-nitro carboxylic acid or a derivative thereof with the corresponding amine, and the nitro group of the obtained 2-amino compound is catalytically activated hydrogen, generator hydrogen Obtained by reduction with a metal or metal salt.

상기에 언급한 바와 같이 일반식(I)의 신규화합물은 약리적으로 유효한 특징을 나타내는데, 특히 중간대사에 영향을 미친다. 일반식(I) 화합물은 특히 지방 저하활성을 나타낸다. 일반식(I)의 화합물은 혈당 강하활성을 지닌 신규 화합물제조의 유용한 중간체이다.As mentioned above, the novel compounds of general formula (I) exhibit pharmacologically effective properties, in particular affecting intermediate metabolism. General formula (I) compound especially shows a fat lowering activity. Compounds of formula (I) are useful intermediates in the preparation of novel compounds with hypoglycemic activity.

다음 화합물에 대해 지방 저하활성을 실험하였다.Fat lowering activity was tested for the following compounds.

A=5-클로로-2-(1,4-디옥사-8-아자-스피로 [4,5-] 데카-8-일)-벤조산A = 5-Chloro-2- (1,4-dioxa-8-aza-spiro [4,5-] deca-8-yl) -benzoic acid

B= 2-(데카하이드로-3-벤즈아제핀) -5-클로로-벤조산B = 2- (Decahydro-3-benzazine) -5-chloro-benzoic acid

C=2-(데카하이드로-3-벤조아제핀)-5-브로모-벤조산C = 2- (Decahydro-3-benzoazine) -5-bromo-benzoic acid

D=5-클로로-2-(4-메톡시-피페리디노)-벤조산D = 5-Chloro-2- (4-methoxy-piperidino) -benzoic acid

1. 지방저하활성1.fat lowering activity

문헌 : 피. 이. 슈어 등 Atherosclerosis Drug Discovery(1976), 편집자 : 시. 이. 데이 ; 플레늄, 뉴오오크, 215페이지Literature: p. this. Shure et al. Atherosclerosis Drug Discovery (1976), editor: poetry. this. day ; Plenium, New Ork, page 215

평균 체중이 100g인 젊은 숫쥐에 10%의 코코넛 지방, 1.5%의 클레스테린, 0.5%의 콜산, 0.2%의 클린클로라이드 및 15%의 서당으로 구성된 사료를 4일간 투여하여 과지방혈증으로 만든다. 시험화합물을 메틸셀룰로스 현탁액으로 하여 위관(stomach tubing)에 의해 계속 2일간 투여한다. 이어서 동물을 밤새 굶기고 시험화합물을 마지막 투여한지 5 내지 24시간 후 혈액을 채취하고 혈청을 분리한다. 혈청에서 콜레스테롤(붸링거 만하임시험 컴비네이션 187.313) 및 트리글리세라이드(붸링거 만하임시험 컴비네이션 126.039)양을 효소적으로 측정한다. Ca++및 헤파린으로 침전시킨 후 β-티포프로테인을 자동분석기를 사용하여 비탁법으로 측정한다. 퍼센트 저하율을 대조 그룹과 비교하여 계산한다.Young males with an average body weight of 100 g are hyperlipidemic with four days of feeding consisting of 10% coconut fat, 1.5% clesterine, 0.5% cholic acid, 0.2% clean chloride and 15% sucrose. The test compound is continuously administered for 2 days by gastrointestinal tubing in methylcellulose suspension. Animals are then starved overnight and blood is collected 5 to 24 hours after the last dose of test compound and serum is separated. Enzymatically determine the amount of cholesterol (Möllinger Mannheim test combination 187.313) and triglycerides (Möllinger Mannheim test combination 126.039) in serum. After precipitation with Ca ++ and heparin, β-tipoproteins are measured by the turbidity method using an automatic analyzer. Percent reduction is calculated by comparison with the control group.

다음 표가 그 결과이다.The following table shows the result.

Figure kpo00003
Figure kpo00003

+물질의 최종 투여 5시간 후의 혈청감소, 다른 수치는 물질의 최종 투여 24시간 후의 측정Serum reduction 5 hours after the last dose of the substance, other values measured 24 hours after the last dose of the substance

2. 급성독성2. Acute Toxicity

체중이 20 내지 26g인 순개의 암, 숫쥐를 사용하여 1회 용량을 경구투여(1% 메틸 셀룰로스현탁액)한 후 급성 독성을 측정한다.Acute toxicity is measured after oral administration (1% methyl cellulose suspension) using a single dose of male cancer and male rats weighing 20 to 26 g.

관찰시간 : 최소 7일Observation time: 7 days minimum

다음 표가 그 결과이다.The following table shows the result.

Figure kpo00004
Figure kpo00004

약리적 특징 때문에 본 발명에 따라 제조한 일반식(I) 화합물은 아테롬성 동맥경화증 및 과지방혈증, 특히 ⅡA형, ⅡB 및 Ⅳ형 치료이 유용하다. 약제학적 투여를 위해 임의로는 다른 활성성분과 함께 사용하여 제피정, 정제, 캅셀제, 좌제, 현탁제 또는 액제 같은 통상적 제형으로 제조할 수 있다. 성인의 1회 용량은 내지 200mg이며, 바람직하게는 5 내지 50mg이며, 1일 용량은 10 내지 500mg, 바람직하게는 15 내지 150mg이다.Because of the pharmacological characteristics, the compounds of formula (I) prepared according to the invention are useful for the treatment of atherosclerosis and hyperlipidemia, in particular type IIA, IIB and IV. For pharmaceutical administration, it may optionally be used in combination with other active ingredients to prepare conventional formulations such as tablets, tablets, capsules, suppositories, suspensions or solutions. The single dose of an adult is from 200 mg, preferably 5 to 50 mg, and the daily dose is 10 to 500 mg, preferably 15 to 150 mg.

다음 실시예는 본 발명을 설명한다.The following examples illustrate the invention.

출발물질의 제조Preparation of Starting Material

[실시예 A]Example A

2-(데카하이드로-이소퀴놀린-2-일)-5-니트로-벤조산2- (Decahydro-isoquinolin-2-yl) -5-nitro-benzoic acid

19g(0.136몰)의 데카하이드로-이소퀴놀린, 27.3g(0.136몰)의 2-클로로-5-니트로-벤조산, 38.6g의 칼륨카보네이트를 500ml의 에탄올 중에서 교반하며 18시간 환류시킨다. 에탄올을 증류한 후, 잔사를 800ml의 물에 용해하고, 2N 염산을 가해 pH 4로 조절하면 반응물이 결정형으로 수득된다.19 g (0.136 mole) of decahydro-isoquinoline, 27.3 g (0.136 mole) of 2-chloro-5-nitro-benzoic acid, 38.6 g of potassium carbonate are refluxed for 18 hours with stirring in 500 ml of ethanol. After distilling off the ethanol, the residue was dissolved in 800 ml of water and adjusted to pH 4 by adding 2N hydrochloric acid to obtain the reaction product in crystalline form.

수득량 : 38g(이론치의 92%)Yield: 38 g (92% of theory)

융 점 : 132 내지 134℃(이소프로판을)Melting Point: 132-134 ° C (Isopropane)

계산치 : C63.14 H6.62 N9.20Calculation: C63.14 H6.62 N9.20

실측치 : 63.02 6.48 9.38Found: 63.02 6.48 9.38

[실시예 B]Example B

2-(1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일)-5-니트로-벤조산2- (1,4-Dioxa-8-aza-spiro [4,5] decan-8-yl) -5-nitro-benzoic acid

20.1g(0.1몰)의 2-클로로-5-니트로-벤조산, 42.9g(0.3몰)의 1,4-디옥사-8-아자-스피로 [4,5] 데칸의 혼합물을 200ml의 에탄올 중에서 환류온도에서 8시간 가열한다. 용매를 증류한 후, 증발잔사를 물에 용해하고 2N 염산을 가해 pH 5.2로 조절하면, 생성물이 침전된다. 이어서 반응생성물을 클로로포름으로 추출하고 나트륨 설페이트상에서 건조하고 용매를 증류한 후 화합물을 결정화한다.A mixture of 20.1 g (0.1 mole) 2-chloro-5-nitro-benzoic acid, 42.9 g (0.3 mole) 1,4-dioxa-8-aza-spiro [4,5] decane was refluxed in 200 ml of ethanol Heat at temperature for 8 hours. After distilling off the solvent, the evaporated residue was dissolved in water and adjusted to pH 5.2 by adding 2N hydrochloric acid, to precipitate the product. The reaction product is then extracted with chloroform, dried over sodium sulphate and the solvent is distilled off to crystallize the compound.

수득량 : 12g(이론치의 39%)Yield: 12 g (39% of theory)

융 점 : 155℃(에탄올)Melting Point: 155 ° C (ethanol)

계산치 : C54.54 H5.24 N9.09Calculated Value: C54.54 H5.24 N9.09

실측치 : 54.20 5.13 8.97Found: 54.20 5.13 8.97

실시예 A 및 B와 유사하게 하여 다음 화합물을 제조한다.Similar to Examples A and B, the following compounds are prepared.

2-(2-메틸-피페리디노)-5-니트로-벤조산2- (2-Methyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 99%, 융점 : 164℃Yield: 99% of theory, Melting point: 164 ° C

2-(3-메틸-피페리디노)-5-니트로-벤조산2- (3-Methyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 85%, 융점 : 161℃Yield: 85% of theory, Melting point: 161 ° C

2-(4-메틸-피페리디노)-5-니트로-벤조산2- (4-Methyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 85%, 융점 : 155℃Yield: 85% of theory, Melting point: 155 ° C

2-(3-에틸-6-메틸-피페리디노)-5-니트로-벤조산2- (3-Ethyl-6-methyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 76%, 융점 : <20℃Yield: 76% of theory, Melting point: <20 ° C

2-(3,5-디메틸-피페리디노)-5-니트로-벤조산2- (3,5-Dimethyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 65%, 융점 : 172℃Yield: 65% of theory, Melting point: 172 ° C

2-(4-메톡시-피페리디노)-5-니트로-벤조산2- (4-Methoxy-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 68%, 융점 : 140℃Yield: 68% of theory, Melting point: 140 ° C

5-니트로-2-(4-페닐-피페리디노)-벤조산5-Nitro-2- (4-phenyl-piperidino) -benzoic acid

수율 : 이론치의 88%, 융점 : 196℃Yield: 88% of theory, Melting point: 196 ° C

2-(4-에톡시카보닐-피페리디노)-5-니트로-벤조산2- (4-Ethoxycarbonyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 82%, 융점 : 160℃Yield: 82% of theory, Melting point: 160 ° C

5-니트로-2-티오모드폴리노-벤조산5-Nitro-2-thiomodolino-benzoic acid

수율 : 이론치의 80%, 융점 : 235℃Yield: 80% of theory, Melting point: 235 ° C

5-니트로-2-(1,2,4,5-테트라하이드로-3-벤즈아제피노)-벤조산5-Nitro-2- (1,2,4,5-tetrahydro-3-benzazino) -benzoic acid

수율 : 이론치의 68%, 융점 : 222℃Yield: 68% of theory, Melting point: 222 ° C

5-니트로-2-(1,2,3,4-테트라하이드로-이소퀴놀리노)-벤조산5-Nitro-2- (1,2,3,4-tetrahydro-isoquinolino) -benzoic acid

수율 : 이론치의 70%, 융점 : 195℃Yield: 70% of theory, Melting point: 195 ° C

5-니트로-2-(4-페닐-피페라지노)-벤조산5-Nitro-2- (4-phenyl-piperazino) -benzoic acid

수율 : 이론치의 88%, 융점 : 196℃Yield: 88% of theory, Melting point: 196 ° C

5-니트로-2-(4-피리딜-(2)-피페라지노)-벤조산5-Nitro-2- (4-pyridyl- (2) -piperazino) -benzoic acid

수율 : 이론치의 66%, 융점 : 192℃Yield: 66% of theory, Melting point: 192 ° C

2-(트란스--3,5-디메틸피페리디노)-5-니트로-벤조산2- (Trans--3,5-dimethylpiperidino) -5-nitro-benzoic acid

수율 : 이론치의 63%, 융점 : 132℃Yield: 63% of theory, Melting point: 132 ° C

2-(3,3,5,5-테트라메틸-피페리디노)-5-니트로-벤조산2- (3,3,5,5-Tetramethyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 98%, 융점 : 138℃Yield: 98% of theory, Melting point: 138 ° C

2-(3,5-디메틸-모르폴리노)-5-니트로-벤조산2- (3,5-Dimethyl-morpholino) -5-nitro-benzoic acid

수율 : 이론치의 75%, 융점 : 164℃Yield: 75% of theory, Melting point: 164 ° C

2-(3,5-디메틸-티오모르폴리노)-5-니트로-벤조산2- (3,5-Dimethyl-thiomorpholino) -5-nitro-benzoic acid

수율 : 이론치의 70%, 융점 : 118℃Yield: 70% of theory, Melting point: 118 ° C

2-(3-아자-비사이클로 [3,2,2] 노난-3-일)-5-니트로-벤조산2- (3-Aza-bicyclo [3,2,2] nonan-3-yl) -5-nitro-benzoic acid

수율 : 이론치의 72%, 융점 : 221℃Yield: 72% of theory, Melting point: 221 ° C

5-니트로-2-노나메틸렌이미노-벤조산5-Nitro-2-nonamethyleneimino-benzoic acid

수율 : 이론치의 80%, 융점 : 127℃Yield: 80% of theory, Melting point: 127 ° C

5-니트로-2-데카메틸렌이미노-벤조산5-Nitro-2-decamethyleneimino-benzoic acid

수율 : 이론치의 92%, 융점 : 128℃Yield: 92% of theory, Melting point: 128 ° C

5-니트로-2-운데카메틸렌이미노-벤조산5-Nitro-2-undecamethyleneimino-benzoic acid

수율 : 이론치의 91%, 융점 : 120℃Yield: 91% of theory, Melting point: 120 ° C

5-니트로-2-도데카메틸렌이미노-벤조산5-Nitro-2-dodecamethyleneimino-benzoic acid

수율 : 이론치의 95%, 융점 : 115℃Yield: 95% of theory, Melting point: 115 ° C

2-(N-메틸-N-페닐아미노)-5-니트로-벤조산2- (N-Methyl-N-phenylamino) -5-nitro-benzoic acid

수율 : 이론치의 10%, 융점 : 115℃Yield: 10% of theory, Melting point: 115 ° C

2-(N-에틸-사이클로헥실아미노)-5-니트로-벤조산2- (N-ethyl-cyclohexylamino) -5-nitro-benzoic acid

수율 : 이론치의 78%, 융점 : 74℃Yield: 78% of theory, Melting point: 74 ° C

2-(N-부틸-N-사이클로헥실아미노)-5-니트로-벤조산2- (N-butyl-N-cyclohexylamino) -5-nitro-benzoic acid

수율 : 이론치의 84%, 융점 : 56℃Yield: 84% of theory, Melting point: 56 ° C

2-(N-사이클로헥실-N-이소부틸아미노)-5-니트로-벤조산2- (N-cyclohexyl-N-isobutylamino) -5-nitro-benzoic acid

수율 : 이론치의 63%, 융점 : <20℃Yield: 63% of theory, Melting Point: <20 ° C

2-(데카하이드로-3-벤즈아제핀-3-일)-5-니트로-벤조산2- (Decahydro-3-benzeazin-3-yl) -5-nitro-benzoic acid

수율 : 이론치의 98%, 융점 : <20℃Yield: 98% of theory, Melting point: <20 ° C

2-(옥타하이드로-이소인돌-2-일)-5-니트로-벤조산2- (Otahydro-isoindol-2-yl) -5-nitro-benzoic acid

수율 : 이론치의 80%, 융점 : 128℃Yield: 80% of theory, Melting point: 128 ° C

2-(4-이소프로필-피페리디노)-5-니트로-벤조산2- (4-Isopropyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 79%, 융점 : 142℃Yield: 79% of theory, Melting point: 142 ° C

2-(4-3급 부틸-피페리디노)-5-니트로-벤조산2- (4-tert-Butyl-piperidino) -5-nitro-benzoic acid

수율 : 이론치의 57%, 융점 : 136℃Yield: 57% of theory, Melting point: 136 ° C

2-(1,4-디옥사-8-아자-스피로 [4,6] 운데칸-8-일)-5-니트로-벤조산2- (1,4-Dioxa-8-aza-spiro [4,6] undecane-8-yl) -5-nitro-benzoic acid

수율 : 이론치의 75%, 융점 : 135℃Yield: 75% of theory, Melting point: 135 ° C

2,4-디피페리디노-5-니트로-벤조산2,4-Dipiperidino-5-nitro-benzoic acid

수율 : 이론치의 31%, 융점 : 152℃Yield: 31% of theory, Melting point: 152 ° C

4-클로로-2-피페리디노-5-니트로-벤조산4-Chloro-2-piperidino-5-nitro-benzoic acid

수율 : 이론치의 18%, 융점 : 133℃Yield: 18% of theory, Melting point: 133 ° C

5-니트로-2-(1,2,3,6-테트라히이드로-피리니노)-벤조산5-Nitro-2- (1,2,3,6-tetrahydro-pyridino) -benzoic acid

수율 : 이론치의 58%, 융점 : 215℃Yield: 58% of theory, Melting point: 215 ° C

2-(N-메틸-N-벤질아미노)-5-니트로-벤조산2- (N-Methyl-N-benzylamino) -5-nitro-benzoic acid

수율 : 이론치의 93%, 융점 : 123 내지 126℃Yield: 93% of theory, Melting point: 123 to 126 ° C

2-[4-(4-클로로페닐)-피페라지노]-5-니트로-벤조산-하이드로클로라이드2- [4- (4-Chlorophenyl) -piperazino] -5-nitro-benzoic acid-hydrochloride

수율 : 이론치의 71.5%, 융점 : 225 내지 227℃(분해)Yield: 71.5% of theory, Melting point: 225 to 227 ° C (decomposition)

2-(4-카브에톡시-피페라지노)-5-니트로-벤조산2- (4-Caethoxy-piperazino) -5-nitro-benzoic acid

수율 : 이론치의 23.1%, 융점 : 155 내지 156℃Yield: 23.1% of theory, Melting point: 155 to 156 ° C

2-[4-(2-푸로일)-피페라지노]-5-니트로-벤조산2- [4- (2-Furoyl) -piperazino] -5-nitro-benzoic acid

수율 : 이론치의 64.8%, 융점 : 200 내지 205℃Yield: 64.8% of theory, Melting point: 200-205 ° C

2-(4-벤질-피페라지노)-5-니트로-벤조산-하이드로클로라이드2- (4-Benzyl-piperazino) -5-nitro-benzoic acid-hydrochloride

수율 : 이론치의 86.6%, 융점 : 142 내지 145℃Yield: 86.6% of theory, Melting point: 142-145 ° C

[실시예 C]Example C

2-헥사메틸렌이미노-5-니트로-벤조산니트릴2-hexamethyleneimino-5-nitro-benzoate nitrile

18.4g(0.11몰)의 2-클로로-5-니트로-벤조산 니트릴 및 22.4g(0.21몰)의 헥사메틸렌이민의 혼합물을 250ml의 에탄올 중에서 4시간 동안 환류시킨다. 냉각한 후, 500ml의 물을 가하면 생성물이 유상으로 침전된다. 침전을 클로로포름에 녹이고, 나트듐 설페이트로 건조하고 클로로포름을 증류한 후, 증발잔사를 에탄올로부터 재결정한다.A mixture of 18.4 g (0.11 mol) of 2-chloro-5-nitro-benzoic acid nitrile and 22.4 g (0.21 mol) of hexamethyleneimine is refluxed in 250 ml of ethanol for 4 hours. After cooling, 500 ml of water was added to precipitate the product into the oil phase. The precipitate is dissolved in chloroform, dried over sodium sulfate and the chloroform is distilled off and the evaporation residue is recrystallized from ethanol.

수득량 : 19.7g(이론치의 73%)Yield: 19.7 g (73% of theory)

융 점 : 70℃Melting Point: 70 ℃

계산치 : C63.65 H6.16 N17.13Calculated Value: C63.65 H6.16 N17.13

실측치 : 63.80 6.07 17.05Found: 63.80 6.07 17.05

[실시예 D]Example D

5-아미노-2-(데카하이드로-이소퀴놀린-2-일)-벤조산5-Amino-2- (decahydro-isoquinolin-2-yl) -benzoic acid

36g(0.118몰)의 2-(데카하이드로-이소퀴놀린-2-일)-5-니트로 벤조산을 250ml의 디메틸포름 아마이드에 용해하고, 촉매로서 10% 팔라듐 목탄의 존재하에 5바(bar)의 수소압하에 실온에서 수소화한다. 수소의 흡수가 완결된 후, 촉매를 여과하고 용매를 진공증류하고 잔사를 에탄올로부터 재결정한다.36 g (0.118 mole) of 2- (decahydro-isoquinolin-2-yl) -5-nitrobenzoic acid is dissolved in 250 ml of dimethylformamide and 5 bar of hydrogen in the presence of 10% palladium charcoal as catalyst Hydrogenate at room temperature under pressure. After the absorption of hydrogen is complete, the catalyst is filtered off, the solvent is distilled off in vacuo and the residue is recrystallized from ethanol.

수득량 : 31.2g(이론치의 96%)Yield: 31.2 g (96% of theory)

융 점 : 252℃Melting Point: 252 ℃

계산치 : C70.04 H8.08 N10.20Calculated Value: C70.04 H8.08 N10.20

실측치 : 70.09 7.85 10.12Found: 70.09 7.85 10.12

[실시예 E]Example E

5-아미노-2-(1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일)-벤조산5-Amino-2- (1,4-dioxa-8-aza-spiro [4,5] decan-8-yl) -benzoic acid

12g(0.039몰)의 2-(1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일)-5-니트로-벤조산을 100ml의 디메틸 포름아마이드 중에서 촉매로서 10% 팔라듐 목탄 존재하에 5바의 수소압에서 수소화한다.12 g (0.039 mol) of 2- (1,4-dioxa-8-aza-spiro [4,5] decane-8-yl) -5-nitro-benzoic acid as a catalyst in 100 ml of dimethyl formamide as a 10% palladium Hydrogenate at 5 bar hydrogen pressure in the presence of charcoal.

수소의 흡수가 완결된 후, 촉매를 여과하고 용매를 증류하고 에탄올로부터 재결정한다.After the absorption of hydrogen is complete, the catalyst is filtered off, the solvent is distilled off and recrystallized from ethanol.

수득량 : 9g(이론치의 83%)Yield: 9 g (83% of theory)

융 점 : 209℃Melting Point: 209 ℃

계산치 : C60.42 H6.56 N10.07Calculation: C60.42 H6.56 N10.07

실측치 : 60.18 6.58 10.12Found: 60.18 6.58 10.12

실시예 D 및 E의 비슷하게 하여 다음 화합물을 제조한다.The following compounds are prepared by analogy of Examples D and E.

5-아미노-2-피롤리디노-벤조산5-Amino-2-pyrrolidino-benzoic acid

수율 : 이론치의 79%, 융점 : 208℃Yield: 79% of theory, Melting point: 208 ° C

5-아미노-2-(2-메틸-피페리디노)-벤조산5-Amino-2- (2-methyl-piperidino) -benzoic acid

수율 : 이론치의 84%, 융점 : 240℃Yield: 84% of theory, Melting point: 240 ° C

5-아미노-2-(3-메틸-피페리디노)-벤조산5-Amino-2- (3-methyl-piperidino) -benzoic acid

수율 : 이론치의 75%, 융점 : 192℃Yield: 75% of theory, Melting point: 192 ° C

5-아미노-2-(4-메틸-피페리디노)-벤조산5-Amino-2- (4-methyl-piperidino) -benzoic acid

수율 : 이론치의 88%, 융점 : 215℃Yield: 88% of theory, Melting point: 215 ° C

5-아미노-2-(3-에틸-6-메틸-피페리디노)-벤조산5-Amino-2- (3-ethyl-6-methyl-piperidino) -benzoic acid

수율 : 이론치의 59%, 융점 : 219℃Yield: 59% of theory, Melting point: 219 ° C

5-아미노-2-(시스-3,5-디메틸-피페리디노)-벤조산5-Amino-2- (cis-3,5-dimethyl-piperidino) -benzoic acid

수율 : 이론치의 87%, 융점 : 234℃Yield: 87% of theory, Melting point: 234 ° C

5-아미노-2-(4-메톡시-피페리디노)-벤조산5-Amino-2- (4-methoxy-piperidino) -benzoic acid

수율 : 이론치의 80%, 융점 : 228℃Yield: 80% of theory, Melting point: 228 ° C

5-아미노-2-헵타메틸렌이미노-벤조산5-Amino-2-heptamethyleneimino-benzoic acid

수율 : 이론치의 64%, 융점 : 214℃Yield: 64% of theory, Melting point: 214 ° C

5-아미노-2-(4-페닐-피페리디노)-벤조산5-Amino-2- (4-phenyl-piperidino) -benzoic acid

수율 : 이론치의 76%, 융점 : 275℃Yield: 76% of theory, Melting point: 275 ℃

5-아미노-2-(4-에톡시카보닐-피페리디노)-벤조산5-Amino-2- (4-ethoxycarbonyl-piperidino) -benzoic acid

수율 : 이론치의 85%, 융점 : 203℃Yield: 85% of theory, Melting point: 203 ° C

5-아미노-2-티오모르폴리노-벤조산5-Amino-2-thiomorpholino-benzoic acid

수율 : 이론치의 76%, 융점 : 193℃Yield: 76% of theory, Melting point: 193 ° C

5-아미노-2-(1,2,4,5-테트라하이드로-3-벤즈아제피노)-벤조산5-Amino-2- (1,2,4,5-tetrahydro-3-benzazino) -benzoic acid

수율 : 이론치의 86%, 융점 : 258℃Yield: 86% of theory, Melting point: 258 ° C

5-아미노-2-(1,2,3,4-테트라하이드로-이소퀴놀리노)-벤조산5-Amino-2- (1,2,3,4-tetrahydro-isoquinolino) -benzoic acid

수율 : 이론치의 66%, 융점 : 220℃Yield: 66% of theory, Melting point: 220 ° C

5-아미노-2-(4-페닐-피페라지노)-벤조산5-Amino-2- (4-phenyl-piperazino) -benzoic acid

수율 : 이론치의 83%, 융점 : 255℃Yield: 83% of theory, Melting point: 255 ° C

5-아미노-2-(4-피리딜-(2)-피페라지노)-벤조산5-Amino-2- (4-pyridyl- (2) -piperazino) -benzoic acid

수율 : 이론치의 80%, 융점 : 248℃Yield: 80% of theory, Melting point: 248 ℃

5-아미노-2-(트란스-3,5-디메틸-피페리디노)-벤조산5-Amino-2- (trans-3,5-dimethyl-piperidino) -benzoic acid

수율 : 이론치의 89%, 융점 : 156℃Yield: 89% of theory, Melting point: 156 ° C

5-아미노-2-(3,3,5,5-테트라메틸-피페리디노)-벤조산5-Amino-2- (3, 3,5,5-tetramethyl-piperidino) -benzoic acid

수율 : 이론치의 98%, 융점 : <20℃Yield: 98% of theory, Melting point: <20 ° C

5-아미노-2-(3,5디메틸-모르폴리노)-벤조산5-Amino-2- (3,5dimethyl-morpholino) -benzoic acid

수율 : 이론치의 83%, 융점 : 255℃Yield: 83% of theory, Melting point: 255 ° C

5-아미노-2-(3,5-디메틸-티오모르폴리노)-벤조산5-Amino-2- (3,5-dimethyl-thiomorpholino) -benzoic acid

수율 : 이론치의 50%, 융점 : 233℃Yield: 50% of theory, Melting point: 233 ° C

5-아미노-2-(3-아자-비사이클로 [3,2,2] 노난-3-일)-벤조산5-Amino-2- (3-aza-bicyclo [3,2,2] nonan-3-yl) -benzoic acid

수율 : 이론치의 86%, 융점 : 288℃Yield: 86% of theory, Melting point: 288 ℃

5-아미노-2-옥타메틸렌이미노-벤조산5-Amino-2-octamethyleneimino-benzoic acid

수율 : 이론치의 88%, 융점 : 191℃Yield: 88% of theory, Melting point: 191 ° C

5-아미노-2-노나메틸렌이미노-벤조산5-Amino-2-nonamethyleneimino-benzoic acid

수율 : 이론치의 80%, 융점 : 212℃Yield: 80% of theory, Melting point: 212 ° C

5-아미노-2-데카메틸렌아미노-벤조산5-Amino-2-decamethyleneamino-benzoic acid

수율 : 이론치의 52%, 융점 : 202℃Yield: 52% of theory, Melting point: 202 ° C

5-아미노-2-운데카메틸렌이미노-벤조산5-Amino-2-undecamethyleneimino-benzoic acid

수율 : 이론치의 93%, 융점 : 242℃Yield: 93% of theory, Melting point: 242 ° C

5-아미노-2-도데카메틸렌이미노-벤조산5-Amino-2-dodecamethyleneimino-benzoic acid

수율 : 이론치의 59%, 융점 : 224℃Yield: 59% of theory, Melting point: 224 ° C

5-아미노-5-(N-메틸-N-페닐아미노)-벤조산5-Amino-5- (N-methyl-N-phenylamino) -benzoic acid

수율 : 이론치의 47%, 융점 : 184℃Yield: 47% of theory, Melting point: 184 ° C

5-아미노-2-(N-에틸-N-사이클로헥실아미노)-벤조산5-Amino-2- (N-ethyl-N-cyclohexylamino) -benzoic acid

수율 : 이론치의 66%, 융점 : 160℃Yield: 66% of theory, Melting point: 160 ° C

5-아미노-2-(N-부틸-N-사이클로헥실아미노)-벤조산5-Amino-2- (N-butyl-N-cyclohexylamino) -benzoic acid

수율 : 이론치의 48% 융점 : 140℃Yield: 48% of theory Melting Point: 140 ° C

5-아미노-2-(N-사이클로헥실-N-이소부틸아미노)-벤조산5-Amino-2- (N-cyclohexyl-N-isobutylamino) -benzoic acid

수율 : 이론치의 62%, 융점 : <20℃Yield: 62% of theory, Melting Point: <20 ° C

5-아미노-2-(데카하이드로-3-벤즈아제핀-3-일)-벤조산5-Amino-2- (decahydro-3-benazazin-3-yl) -benzoic acid

수율 : 이론치의 54%, 융점 : 204℃Yield: 54% of theory, Melting point: 204 ° C

5-아미노-2-(옥타하이드로-인소인돌-2-일)-벤조산5-Amino-2- (octahydro-phosphoindol-2-yl) -benzoic acid

수율 : 이론치의 43%, 융점 : 228℃Yield: 43% of theory, Melting point: 228 ° C

5-아미노-2-(4-이소프로필-피페리디노)-벤조산5-Amino-2- (4-isopropyl-piperidino) -benzoic acid

수율 : 이론치의 50%, 융점 : 231℃Yield: 50% of theory, Melting point: 231 ° C

5-아미노-2-(4-3급 부틸-피페리디노)-벤조산5-Amino-2- (4-tert-butyl piperidino) -benzoic acid

수율 : 이론치의 81%, 융점 : 276℃Yield: 81% of theory, Melting point: 276 ° C

5-아미노-2-(1,4-디옥사-8-아자-스피로 [4,6] 운데칸-8-일)-벤조산5-Amino-2- (1,4-dioxa-8-aza-spiro [4,6] undecane-8-yl) -benzoic acid

수율 : 이론치의 49%, 융점 : 235℃Yield: 49% of theory, Melting point: 235 ° C

5-아미노-2-(1,2,3,6-테트라하이드로-피리디노)-벤조산5-Amino-2- (1,2,3,6-tetrahydro-pyridino) -benzoic acid

수율 : 이론치의 51%, 융점 : 232℃Yield: 51% of theory, Melting point: 232 ° C

5-아미노-2-(4-메틸-피페라지노)-벤조산 하이드로클로라이드5-Amino-2- (4-methyl-piperazino) -benzoic acid hydrochloride

수율 : 이론치의 90%, 융점 : <20℃Yield: 90% of theory, Melting Point: <20 ° C

5-아미노-2-(N-메틸-N-벤질아미노)-벤조산5-Amino-2- (N-methyl-N-benzylamino) -benzoic acid

수율 : 이론치의 95%, 융점 : <20℃Yield: 95% of theory, Melting Point: <20 ° C

5-아미노-2-[4-(4-클로로-페닐)-피페라지노]-벤조산 염산염5-Amino-2- [4- (4-chloro-phenyl) -piperazino] -benzoic acid hydrochloride

수율 : 이론치의 80.5%, 융점 : 305℃ (분해)Yield: 80.5% of theory, Melting point: 305 ° C (decomposition)

5-아미노-2-(4-카브에톡시-피페라지노)-벤조산5-Amino-2- (4-carethoxy-piperazino) -benzoic acid

수율 : 이론치의 87.5%, 융점 : 195 내지 197℃Yield: 87.5% of theory, Melting point: 195-197 ° C

5-아미노-2-[4-(2-푸로일)-피페라지노]벤조산5-Amino-2- [4- (2-furoyl) -piperazino] benzoic acid

수율 : 이론치의 97%, 융점 : 20℃Yield: 97% of theory, Melting point: 20 ° C

5-아미노-2-(4-벤질-피페라지노)-벤조산 하이드로클로라이드5-Amino-2- (4-benzyl-piperazino) -benzoic acid hydrochloride

수율 : 이론치의 80%, 융점 : 200 내지 210℃Yield: 80% of theory, Melting point: 200-210 ° C

최종 생성물의 제조Preparation of the final product

[실시예 1]Example 1

5-클로로-2-(데카하이드로-이소퀴놀린-2-일)-벤조산5-Chloro-2- (decahydro-isoquinolin-2-yl) -benzoic acid

10g(0.0365몰)의 5-아미노-2(데카하이드로-이소퀴놀린-2-일)-벤조산을 55ml의 중정도의 농도의 염산에 용해하고, 10ml의 물 중에 2.7g(0.039몰)의 나트륨 나이트레이트를 용해한 용액을 0℃에서 적가하여 디아조화한다. 적가가 끝난 후 반응 혼합물을 15분간 고반하고, 40ml의 농염산 중의 4g의 구리분말 현탁액에 이 디아조늄염 응액을 적하한다. 철야 교반한 후, 암녹색의 균일한 응액이 수득되는데, 100ml의 물로 희석하고 클로로포름으로 완전히 추출한다. 나트륨 설페이트상에서 건조한 후, 클로로포름 증발잔사를, 에틸아세테이트/메탄올(9.5 : 0.5)을 용출제로 사용하여 실리카겔 칼럼상 크로마토그라피에 의해 정제한다.10 g (0.0365 moles) of 5-amino-2 (decahydro-isoquinolin-2-yl) -benzoic acid is dissolved in 55 ml of medium concentration hydrochloric acid and 2.7 g (0.039 moles) of sodium nitrate in 10 ml of water The solution which melt | dissolved the rate was added dropwise at 0 degreeC, and diazotization is carried out. After completion of the dropwise addition, the reaction mixture is plated for 15 minutes, and the diazonium salt solution is added dropwise to a suspension of 4 g of copper powder in 40 ml of concentrated hydrochloric acid. After stirring overnight, a dark green uniform solution is obtained, diluted with 100 ml of water and extracted completely with chloroform. After drying over sodium sulphate, the chloroform evaporation residue is purified by chromatography on silica gel column using ethyl acetate / methanol (9.5: 0.5) as eluent.

수득량 : 4.8g(이론치의 45%)Yield: 4.8 g (45% of theory)

융 점 : 138℃Melting Point: 138 ℃

계산치 : C65.41, H6.85 N4.76 Cl12.06Calculation: C65.41, H6.85 N4.76 Cl12.06

실측치 : 65.51, 7.07 4.89 12.32Found: 65.51, 7.07 4.89 12.32

[실시예 2]Example 2

5-클로로-2-(1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일)-벤조산5-Chloro-2- (1,4-dioxa-8-aza-spiro [4,5] decan-8-yl) -benzoic acid

8.5g(0.031몰)의 5-아미노-2-(1,4-디옥사-8-아자-스피로 [4,5] 데칸-8-일)-벤조산을 28ml의 중염산에 용해하고 10ml의 물 중의 2.4g(0.034몰)의 나트륨 나이트라이트 용액으로 0℃에서 디아조화한다. 디아조늄염 용액을 교반하면서, 3ml의 농염산 중의 3g의 구리분말 현탁액에 적하한다. 질소생성이 완결된후, 반응혼합물을 2시간 교반하고 물로 희석하고 클로로포름으로 추출한다. 나트륨 설페이트상에서 건조한후, 용매를 증류하고, 증발잔사를 석유에테르로 온침시키면 6.1g(이론치의 66%)의 화합물이 수득된다.8.5 g (0.031 mol) of 5-amino-2- (1,4-dioxa-8-aza-spiro [4,5] decan-8-yl) -benzoic acid is dissolved in 28 ml of dihydrochloric acid and 10 ml of water Diazolation at 0 ° C. with 2.4 g (0.034 moles) of sodium nitrite solution in water. While stirring the diazonium salt solution, it is dripped at 3 g of copper powder suspension in 3 ml of concentrated hydrochloric acid. After nitrogen production is complete, the reaction mixture is stirred for 2 hours, diluted with water and extracted with chloroform. After drying over sodium sulphate, the solvent is distilled off and the evaporation residue is warmed with petroleum ether to give 6.1 g (66% of theory) of the compound.

융 점 : 180℃Melting Point: 180 ℃

계산치 : C56.47 H5.42 N4.71Calculated Value: C56.47 H5.42 N4.71

실측치 : 56.11 5.37 4.83Found: 56.11 5.37 4.83

실시예 1 및 2와 비슷하게 하여 다음 화합물을 제조한다.Similar to Examples 1 and 2 to prepare the following compounds.

5-클로로-2-피롤리디노-벤조산5-Chloro-2-pyrrolidino-benzoic acid

수율 : 이론치의 30%, 융점 : 164℃Yield: 30% of theory, Melting point: 164 ℃

5-클로로-2-(2-메틸-피페리디노)-벤조산5-Chloro-2- (2-methyl-piperidino) -benzoic acid

수율 : 이론치의 74%, 융점 : 124℃Yield: 74% of theory, Melting point: 124 ° C

5-클로로-2-(3-메틸-피페리디노)-벤조산5-Chloro-2- (3-methyl-piperidino) -benzoic acid

수율 : 이론치의 47%, 융점 : 165℃Yield: 47% of theory, Melting point: 165 ° C

5-클로로-2-(4-메틸-피페리디노)-벤조산5-Chloro-2- (4-methyl-piperidino) -benzoic acid

수율 : 이론치의 52%, 융점 : 107℃Yield: 52% of theory, Melting point: 107 ° C

2-(3-에틸-6-메틸-피페리디노)-5-클로로-벤조산2- (3-Ethyl-6-methyl-piperidino) -5-chloro-benzoic acid

수율 : 이론치의 73%, 융점 : <20℃Yield: 73% of theory, Melting Point: <20 ° C

5-클로로-2-(시스-3,5-디메틸-피페리디노)-벤조산5-Chloro-2- (cis-3,5-dimethyl-piperidino) -benzoic acid

수율 : 이론치의 46%, 융점 : 167℃Yield: 46% of theory, Melting point: 167 ° C

5-클로로-2-(트란스-3,5-디메틸-피페리디노)-벤조산5-Chloro-2- (trans-3,5-dimethyl-piperidino) -benzoic acid

수율 : 이론치의 63%, 융점 : 132℃Yield: 63% of theory, Melting point: 132 ° C

5-클로로-2-(4-메톡시-피페리디노)-벤조산5-Chloro-2- (4-methoxy-piperidino) -benzoic acid

수율 : 이론치의 63%, 융점 : 136℃Yield: 63% of theory, Melting point: 136 ° C

5-클로로-2-헵타메틸렌이미노-벤조산5-Chloro-2-heptamethyleneimino-benzoic acid

수율 : 이론치의 58%, 융점 : <20℃Yield: 58% of theory, Melting point: <20 ° C

5-클로로-2-(4-페닐-피페리디노)-벤조산5-Chloro-2- (4-phenyl-piperidino) -benzoic acid

수율 : 이론치의 51%, 융점 : 217℃Yield: 51% of theory, Melting point: 217 ° C

5-클로로-2-(4-에톡시카보닐-피페리디노)-벤조산5-Chloro-2- (4-ethoxycarbonyl-piperidino) -benzoic acid

수율 : 이론치의 97%, 융점 : <20℃Yield: 97% of theory, Melting Point: <20 ° C

5-클로로-2-헥사메틸렌이미노-벤조산5-Chloro-2-hexamethyleneimino-benzoic acid

수율 : 이론치의 34%, 융점 : 113℃Yield: 34% of theory, Melting point: 113 ° C

5-클로로-2-티오모르폴리노-벤조산5-Chloro-2-thiomorpholino-benzoic acid

수율 : 이론치의 16%, 융점 : 160℃Yield: 16% of theory, Melting point: 160 ° C

5-클로로-2-(1,2,4,5-테트라하이드로-3-벤즈아제피노)-벤조산5-Chloro-2- (1,2,4,5-tetrahydro-3-benzazino) -benzoic acid

수율 : 이론치의 59%, 융점 : 174℃Yield: 59% of theory, Melting point: 174 ° C

5-클로로-2-(1,2,3,4-테트라하이드로-이소퀴놀리노)-벤조산5-Chloro-2- (1,2,3,4-tetrahydro-isoquinolino) -benzoic acid

수율 : 이론치의 50%, 융점 : 182℃Yield: 50% of theory, Melting point: 182 ° C

5-클로로-2-(4-페닐-피페라지노)-벤조산5-Chloro-2- (4-phenyl-piperazino) -benzoic acid

수율 : 이론치의 42%, 융점 : 154℃Yield: 42% of theory, Melting point: 154 ° C

5-클로로-2-(4-피리딜-(2)-피페라지노)-벤조산5-Chloro-2- (4-pyridyl- (2) -piperazino) -benzoic acid

수율 : 이론치의 45%, 융점 : 168℃Yield: 45% of theory, Melting point: 168 ° C

5-브로모-2-(2-메틸-피페리디노)-벤조산5-Bromo-2- (2-methyl-piperidino) -benzoic acid

수율 : 이론치의 31%, 융점 : 168℃Yield: 31% of theory, Melting point: 168 ° C

5-클로로-2-(3,3,5,5-테트라메틸-피페리디노)-벤조산5-Chloro-2- (3,3,5,5-tetramethyl-piperidino) -benzoic acid

수율 : 이론치의 62%, 융점 : <20℃Yield: 62% of theory, Melting Point: <20 ° C

5-브로모-2-(4-메톡시-피페리디노)-벤조산5-Bromo-2- (4-methoxy-piperidino) -benzoic acid

수율 : 이론치의 48%, 융점 : 138℃Yield: 48% of theory, Melting point: 138 ° C

5-클로로-2-(3,5-디메틸모르폴리노)-벤조산5-Chloro-2- (3,5-dimethylmorpholino) -benzoic acid

수율 : 이론치의 50%, 융점 : 174℃Yield: 50% of theory, Melting point: 174 ° C

5-클로로-2-(3,5-디메틸-티오모르폴리노)-벤조산5-Chloro-2- (3,5-dimethyl-thiomorpholino) -benzoic acid

수율 : 이론치의 18%, 융점 : 134℃Yield: 18% of theory, Melting point: 134 ° C

5-브로모-2-헵타메틸렌이미노-벤조산5-Bromo-2-heptamethyleneimino-benzoic acid

수율 : 이론치의 15%, 융점 : 104℃Yield: 15% of theory, Melting point: 104 ° C

5-클로로-2-(3-아자-비사이클로 [3,2,2] 노난-3-일)-벤조산5-Chloro-2- (3-aza-bicyclo [3,2,2] nonan-3-yl) -benzoic acid

수율 : 이론치의 16%, 융점 : 199℃Yield: 16% of theory, Melting point: 199 ° C

5-클로로-2-옥타메틸렌이미노-벤조산5-Chloro-2-octamethyleneimino-benzoic acid

수율 : 이론치의 70%, 융점 : 84℃Yield: 70% of theory, Melting point: 84 ° C

5-클로로-2-노나메틸렌이미노-벤조산5-Chloro-2-nonamethyleneimino-benzoic acid

수율 : 이론치의 30%, 융점 : 78℃Yield: 30% of theory, Melting point: 78 ° C

5-클로로-2-데카메틸렌이미노-벤조산5-Chloro-2-decamethyleneimino-benzoic acid

수율 : 이론치의 65%, 융점 : 70℃Yield: 65% of theory, Melting point: 70 ° C

5-클로로-2-운데카메틸렌이미노-벤조산5-Chloro-2-undecamethyleneimino-benzoic acid

수율 : 이론치의 41%, 융점 : 41℃Yield: 41% of theory, Melting point: 41 ° C

5-클로로-2-도데카메틸렌이미노-벤조산5-Chloro-2-dodecamethyleneimino-benzoic acid

수율 : 이론치의 36%, 융점 : 40℃Yield: 36% of theory, Melting point: 40 ° C

5-클로로-2-(N-페닐-N-메틸아미노)-벤조산5-Chloro-2- (N-phenyl-N-methylamino) -benzoic acid

수율 : 이론치의 27%, 융점 : 164℃Yield: 27% of theory, Melting point: 164 ° C

2-(N-에틸-N-사이클로헥실아미노)-5-클로로-벤조산2- (N-ethyl-N-cyclohexylamino) -5-chloro-benzoic acid

수율 : 이론치의 24%, 융점 : 152℃Yield: 24% of theory, Melting point: 152 ° C

2-(N-부틸-N-사이클로헥실아미노)-5-클로로-벤조산2- (N-butyl-N-cyclohexylamino) -5-chloro-benzoic acid

수율 : 이론치의 16%, 융점 : 145℃Yield: 16% of theory, Melting point: 145 ° C

5-클로로-2-(N-사이클로헥실-N-이소부틸아미노)-벤조산5-Chloro-2- (N-cyclohexyl-N-isobutylamino) -benzoic acid

수율 : 이론치의 22%, 융점 : 131℃Yield: 22% of theory, Melting point: 131 ° C

5-클로로-2-(데카하이드로-3-벤즈아제핀-3-일)-벤조산5-Chloro-2- (decahydro-3-benzeazin-3-yl) -benzoic acid

수율 : 이론치의 70%, 융점 : 153℃Yield: 70% of theory, Melting point: 153 ° C

5-브로모-2-(데카하이드로-3-벤즈아제핀-3-일)-벤조산5-Bromo-2- (decahydro-3-benzeazin-3-yl) -benzoic acid

수율 : 이론치의 54%, 융점 : 154℃Yield: 54% of theory, Melting point: 154 ° C

5-클로로-2-(옥타하이드로-이소인돌-2-일)-벤조산5-Chloro-2- (octahydro-isoindol-2-yl) -benzoic acid

수율 : 이론치의 33%, 융점 : 164℃Yield: 33% of theory, Melting point: 164 ° C

5-브로모-2-옥타메틸렌이미노-벤조산5-Bromo-2-octamethyleneimino-benzoic acid

수율 : 이론치의 48%, 융점 : 94℃Yield: 48% of theory, Melting point: 94 ° C

5-클로로-2-(4-이소프로필-피페리디노)-벤조산5-Chloro-2- (4-isopropyl-piperidino) -benzoic acid

수율 : 이론치의 43%, 융점 : 172℃Yield: 43% of theory, Melting point: 172 ° C

5-클로로-2-(4-3급부틸-피페리디노)-벤조산5-Chloro-2- (4-tert-butyl-piperidino) -benzoic acid

수율 : 이론치의 35%, 융점 : 161℃Yield: 35% of theory, Melting point: 161 ° C

5-클로로-2-(1,4-디옥사-8-아자-스피로 [4,6] 운데칸-8-일)-벤조산5-Chloro-2- (1,4-dioxa-8-aza-spiro [4,6] undecane-8-yl) -benzoic acid

수율 : 이론치의 42%, 융점 : 163℃Yield: 42% of theory, Melting point: 163 ° C

5-클로로-2-(1,2,3,6-테트라하이드로-피리디노)-벤조산5-Chloro-2- (1,2,3,6-tetrahydro-pyridino) -benzoic acid

수율 : 이론치의 73%, 융점 : 173℃Yield: 73% of theory, Melting point: 173 ° C

5-클로로-2-(4-메틸-피페라지노)-벤조산 하이드로클로라이드5-Chloro-2- (4-methyl-piperazino) -benzoic acid hydrochloride

수율 : 이론치의 75%, 융점 : 132℃ (분해)Yield: 75% of theory, Melting point: 132 ° C (decomposition)

5-클로로-2-(N-메틸-N-벤질아미노)-벤조산5-Chloro-2- (N-methyl-N-benzylamino) -benzoic acid

수율 : 이론치의 18.2%, 융점 : 156 내지 157℃Yield: 18.2% of theory, Melting point: 156 to 157 ° C

5-클로로-2-[4-(4-클로로-페닐)-피페라지노] 벤조산5-Chloro-2- [4- (4-chloro-phenyl) -piperazino] benzoic acid

수율 : 이론치의 30.5%, 융점 : 228 내지 230℃Yield: 30.5% of theory, Melting point: 228 to 230 ° C

5-클로로-2-[4-(2-푸로일)-피페라지노] 벤조산5-Chloro-2- [4- (2-furoyl) -piperazino] benzoic acid

수율 : 이론치의 33.1%, 융점 : 200 내지 202℃Yield: 33.1% of theory, Melting Point: 200-202 ° C

2-(4-벤질-피페라지노)-5-클로로-벤조산 하이드로클로라이드2- (4-Benzyl-piperazino) -5-chloro-benzoic acid hydrochloride

수율 : 이론치의 42.8%, 융점 : 230 내지 232℃Yield: 42.8% of theory, Melting point: 230 to 232 ° C

[실시예 3]Example 3

5-클로로-2-헥사메틸렌이미노-벤조산 니트릴5-Chloro-2-hexamethyleneimino-benzoic acid nitrile

20g(0.092몰)의 5-아미노-2-헥사메틸렌이미노-벤조산 니트릴을 90ml의 중염산에 용해하고 0℃에서 30ml의 물 중의 6.5g(0.094몰)의 나트륨 나이트라이트 용액을 적가하여 디아조화한다. 적가가 끝난 후 반응혼합물을 15분간 교반한다. 70℃로 가온한, 농염산 중의 염화구리(I) 용액에, 디아조늄염 용액을 교반하여 적하한다. 질소생성이 완결된 후, 반응용액을 클로로포름으로 추출한다. 나트륨 설페이트상에서 건조하고, 클로로포름을 증류한 후, 증발잔사를 실리카겔 칼럼상 크로마토그라피에 의해(용출제 : 틀루엔) 정제한다.20 g (0.092 mole) of 5-amino-2-hexamethyleneimino-benzoic acid nitrile is dissolved in 90 ml of dihydrochloric acid and diazotized by dropwise addition of a 6.5 g (0.094 mole) sodium nitrite solution in 30 ml of water at 0 ° C. do. After the addition is completed, the reaction mixture is stirred for 15 minutes. The diazonium salt solution is stirred and dripped at the copper chloride (I) solution in concentrated hydrochloric acid heated at 70 degreeC. After nitrogen formation is complete, the reaction solution is extracted with chloroform. After drying over sodium sulfate and distilling chloroform, the evaporated residue is purified by chromatography on silica gel column (eluant: toluene).

수득량 : 5g(이론치의 23%)Yield: 5 g (23% of theory)

응 점 : <20℃Condensation Point: <20 ℃

[실시예 4]Example 4

5-클로로-2-헥사메틸렌이미노-벤조산5-Chloro-2-hexamethyleneimino-benzoic acid

5g(0.021몰)의 5-클로로-2-헥사메틸렌이미노-벤조산 니트릴을 32g의 수산화칼륨용액 및 20ml의 물중에서 170℃까지, 8시간 가열한다. 냉각한 용융물을 물에 용해하고 pH를 5로 산성화하면 아마이드가 정량적으로 침전된다. 중염산으로 가수분해하여 3.6g(이론치의 67.4%)의 화합물이 수득된다.5 g (0.021 mol) of 5-chloro-2-hexamethyleneimino-benzoic acid nitrile is heated to 170 ° C. in 32 g of potassium hydroxide solution and 20 ml of water for 8 hours. When the cooled melt is dissolved in water and acidified to pH 5, the amide precipitates quantitatively. Hydrolysis with dihydrochloric acid yields 3.6 g (67.4% of theory) of the compound.

융 점 : 113℃Melting Point: 113 ℃

실시예 3 내지 4와 비슷하게 하여 다음 화합물을 제조한다.Similarly to Examples 3 to 4, the following compounds were prepared.

5-클로로-2-모르폴리노-벤조산 니트릴5-Chloro-2-morpholino-benzoic acid nitrile

수율 : 이론치의 20%, 융점 : 57℃Yield: 20% of theory, Melting point: 57 ° C

5-클로로-2-모르폴리노-벤즈아마이드5-chloro-2-morpholino-benzamide

수율 : 이론치의 98%, 융점 : 280℃Yield: 98% of theory, Melting point: 280 ° C

5-클로로-2-모르폴리노-벤조산5-Chloro-2-morpholino-benzoic acid

수율 : 이론치의 60%, 융점 : 157℃Yield: 60% of theory, Melting Point: 157 ℃

[실시예 5]Example 5

5-시아노-2-옥타메틸렌이미노-벤조산5-Cyano-2-octamethyleneimino-benzoic acid

26.2g(0.1몰)의 5-아미노-2-옥타메틸렌이미노-벤조산을 38ml의 농염산에 용해하고 280ml의 물을 가하고 30ml의 물 중의 7.6g(0.11몰)의 나트륨 나이트라이트 용액을 0℃에서 적가하여 디아조화한다. 30분간 교반한 후, 용액을 나트륨 카보네이트에 의해 pH 7로 조절한다. 이어서 삼나트륨-테트라시아노-구리(I)착염용액을 0℃에서 디아조늄염 용액에 적가한다. 구리(I) 착염용액은 다음과 같이 수득한다.26.2 g (0.1 mole) of 5-amino-2-octamethyleneimino-benzoic acid was dissolved in 38 ml of concentrated hydrochloric acid, 280 ml of water was added and 7.6 g (0.11 mole) of sodium nitrite solution in 30 ml of water was added to 0 ° C. Add drop by to diazotize. After stirring for 30 minutes, the solution is adjusted to pH 7 with sodium carbonate. Trisodium-tetracyano-copper (I) complex salt solution is then added dropwise to the diazonium salt solution at 0 ° C. A copper (I) complex salt solution is obtained as follows.

100ml의 물 중의 32g(0.128몰)의 황산구리 5H2O 및 8.7g의 염화나트륨을 50ml의 물에 6.6g(0.0635몰)의 나트륨 하이드르겐 설피트 및 4.4g의 수산화나트륨을 용해한 나트륨 하이드로겐 설피트 용액으로 염화구리(I)로 환원시킨다. 침전된 염화구리(I)를 흡인여과하여 50ml의 물에 현탁시키고 30ml의 물에 17g(0.346몰)의 나트륨 시아나이드를 용해한 용액 중에 용해한다. 질소생성이 완결된 후, 반응혼합물을 70℃까지 1시간 가열한다. 반응혼합물을 냉각한 후, 2N염산으로 pH 5.5로 조절하고, 클로로포름으로 추출한다. 클로로포름상을 나트륨 설페이트상에서 건조하고, 클로로포름을 증류한 후, 수득된 조생성물을 에틸아세테이트를 용출제로 하는 실리카켈 칼럼상에서 정제한다.32 g (0.128 mole) copper sulfate 5H 2 O and 8.7 g sodium chloride in 100 ml of water dissolved in 6.6 g (0.0635 mole) of sodium hydrogen sulfite and 4.4 g of sodium hydroxide in 50 ml of water. The solution is reduced to copper chloride (I). The precipitated copper chloride (I) was suction filtered and suspended in 50 ml of water and dissolved in a solution of 17 g (0.346 mol) of sodium cyanide in 30 ml of water. After nitrogen production was completed, the reaction mixture was heated to 70 ° C. for 1 hour. After cooling the reaction mixture, the mixture was adjusted to pH 5.5 with 2N hydrochloric acid and extracted with chloroform. The chloroform phase is dried over sodium sulfate, the chloroform is distilled off, and the crude product obtained is purified on a silica gel column with ethyl acetate as the eluent.

수득량 : 9g(이론치의 30%)Yield: 9 g (30% of theory)

융 점 : 20℃Melting Point: 20 ℃

계산치 : C70.56 H7.40 N10.28Calculation: C70.56 H7.40 N10.28

실측치 : 70.38 7.20 10.10Found: 70.38 7.20 10.10

[실시예 6]Example 6

2-헵타메틸렌이미노-5-하이드록시-벤조산2-heptamethyleneimino-5-hydroxy-benzoic acid

26.7g(0.107몰)의 5-아미노-2-헵타메틸렌이미노-벤조산을 190ml의 3N 황산에 용해하고, 30ml의 물에 8.3g(0.12몰)의 나트륨 나이트 라이트를 용해한 용액을 0℃에서 적가하여 디아조화한다. 30분간 교반한 후, 2g의 분쇄한 우레아를 가한다. 90℃로 가온한 320ml의 50% 황산에 디아조늄염 용액을 교반하여 적가한다. 질소생성이 완결된 후, 실온에서 반응혼합물을 암모니아로 pH 4로 조절하고 클로로포름으로 추출한다. 나트륨 설페이트상에서 건조하고, 클로로포름을 증류한 후 수득한 건조잔사를 클로로포름을 용출제로하는 실리카켈 칼럼상에서 정제한다. 이소프로판올로부터 재결정한 후 8g(이론치의 30%)의 화합물을 수득한다.26.7 g (0.107 mole) of 5-amino-2-heptamethyleneimino-benzoic acid was dissolved in 190 ml of 3N sulfuric acid, and a solution of 8.3 g (0.12 mole) of sodium nitrite in 30 ml of water was added dropwise at 0 ° C. To diazotize. After stirring for 30 minutes, 2 g of crushed urea are added. The diazonium salt solution was stirred and added dropwise to 320 ml of 50% sulfuric acid heated to 90 ° C. After nitrogen production is complete, the reaction mixture is adjusted to pH 4 with ammonia at room temperature and extracted with chloroform. After drying over sodium sulfate and distilling chloroform, the dried residue obtained is purified on a silica gel column with chloroform as eluent. After recrystallization from isopropanol 8 g (30% of theory) of the compound are obtained.

융 점 : 190℃Melting Point: 190 ℃

계산치 : C67.45 H7.68 N5.61Calculation: C67.45 H7.68 N5.61

실측치 : 66.87 7.71 5.65Found: 66.87 7.71 5.65

실시예 6과 비슷하게 하여 다음 화합물을 제조한다.In the same manner as in Example 6, the following compounds were prepared.

2-헥사메틸렌이미노-5-하이드록시-벤조산2-hexamethyleneimino-5-hydroxy-benzoic acid

수율 : 이론치의 24%, 융점 : 214℃Yield: 24% of theory, Melting point: 214 ° C

5-하이드록시-2-옥타메틸렌이미노-벤조산5-Hydroxy-2-octamethyleneimino-benzoic acid

수율 : 이론치의 24%, 융점 : 208℃Yield: 24% of theory, Melting point: 208 ° C

5-하이드록시-2-(4-3급부틸-피페리딘) 벤조산5-hydroxy-2- (4-tert-butyl-piperidine) benzoic acid

수율 : 이론치의 33%, 융점 : 240℃Yield: 33% of theory, Melting point: 240 ° C

5-하이드록시-2-(시스--3,5-디메틸-피페리디노)-벤조산5-Hydroxy-2- (cis--3,5-dimethyl-piperidino) -benzoic acid

수율 : 이론치의 67.4%, 융점 : 248 내지 250℃Yield: 67.4% of theory, Melting point: 248 to 250 ° C

Claims (1)

일반식(Ⅱ)의 화합물을 나이트라이트에 의해 디아조늄염으로 전환시키고, 수득한 디아조늄염을 황산 및 구리 또는 상응하는 구리-(I)-염 존재하에 가열하여 일반식(I) 화합물로 전환시킴을 특징으로 하여 일반식(I)의 신규한 2-아미노-벤조산 유도체 및 그의 산부가염 및 염기염을 제조하는 방법The compound of formula (II) is converted to the diazonium salt by nitrite and the diazonium salt obtained is converted to the compound of formula (I) by heating in the presence of sulfuric acid and copper or the corresponding copper- (I) -salts. To prepare novel 2-amino-benzoic acid derivatives of general formula (I) and acid addition salts and base salts thereof
Figure kpo00005
Figure kpo00005
상기식에서 R5는 불소, 염소 또는 브롬원자, 시아노 또는 하이드록시그룹이고,In which R 5 is fluorine, chlorine or bromine atom, cyano or hydroxy group, R6및 R7은 이들이 부착된 질소와 함께 알킬이 탄소수 2 내지 4인 N-알킬-사이클로헥실아미노그룹, 알킬의 탄소수 1 내지 3의 N-알킬-페닐아미노 또는 N-알킬-벤질아미노그룹, 탄소수 6 내지 12인 사이클릭알킬렌이미노그룹, 탄소수 1 내지 4의 알킬그룹, 탄소수 1 내지 3의 알콕시그룹, 총 탄소수 2 내지 4의 알콕시카보닐그룹 또는 페닐그룹으로 치환된 피페리디노그룹, 탄소수 1 내지 3의 알킬그룹, 둘, 셋 또는 넷으로 치환된 피페리디노그룹, 탄소수 1 내지 3의 알킬그룹 하나 또는 둘로 임의 치환된 모르폴리노 또는 티오모르폴리노그룹, 탄소수 1 내지 3의 알킬그룹, 총 탄소수 2 내지 4의 알콕시카보닐그룹, 페닐, 할로겐페닐, 피리딜, 벤질 또는 푸로일그룹으로 4위치가 치환된 피페라지노그룹, 탄소수 7 내지 10의 포화되거나 부분적으로 불포화된 아자-비사이클로알킬그룹, 탄소수 6 내지 9의 1,4-디옥사-8-아자-스피로-알칸그룹, 피롤리디노 또는 테트라하이드로-피리디노그룹이며,R 6 and R 7 together with the nitrogen to which they are attached are N-alkyl-cyclohexylamino group alkyl having 2 to 4 carbon atoms, N-alkyl-phenylamino or N-alkyl-benzylamino group having 1 to 3 carbon atoms of alkyl, A piperidino group substituted with a cyclic alkyleneimino group having 6 to 12 carbon atoms, an alkyl group having 1 to 4 carbon atoms, an alkoxy group having 1 to 3 carbon atoms, an alkoxycarbonyl group having 2 to 4 carbon atoms or a phenyl group, An alkyl group having 1 to 3 carbon atoms, a piperidino group substituted with two, three or four, an morpholino or thiomorpholino group optionally substituted with one or two alkyl groups having 1 to 3 carbon atoms, an alkyl having 1 to 3 carbon atoms Group, piperazino group having 4 positions substituted by alkoxycarbonyl group having 2 to 4 carbon atoms, phenyl, halogenphenyl, pyridyl, benzyl or furoyl group, saturated or partially unsaturated aza- with 7 to 10 carbon atoms anecdote 1,4-dioxa-8-aza claws alkyl group, having 6 to 9-spiro-alkane group, a pyrrolidino or tetrahydro-pyrido a dino group, W는 카복시, 아미노카보닐, 시아노 또는 총 탄소수 2 내지 4의 알콕시카보닐이다.W is carboxy, aminocarbonyl, cyano or alkoxycarbonyl having 2 to 4 carbon atoms in total.
KR1019840004152A 1980-07-12 1984-07-14 Process for preparing carboxylic acid derivatives KR840002235B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019840004152A KR840002235B1 (en) 1980-07-12 1984-07-14 Process for preparing carboxylic acid derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1019800002788A KR840002234B1 (en) 1980-07-12 1980-07-12 Process for preparing 2-amino-benoic acid derivatives
KR1019840004152A KR840002235B1 (en) 1980-07-12 1984-07-14 Process for preparing carboxylic acid derivatives

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1019800002788A Division KR840002234B1 (en) 1980-07-12 1980-07-12 Process for preparing 2-amino-benoic acid derivatives

Publications (1)

Publication Number Publication Date
KR840002235B1 true KR840002235B1 (en) 1984-12-06

Family

ID=26626884

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840004152A KR840002235B1 (en) 1980-07-12 1984-07-14 Process for preparing carboxylic acid derivatives

Country Status (1)

Country Link
KR (1) KR840002235B1 (en)

Similar Documents

Publication Publication Date Title
US4882432A (en) Polycyclic-carbamic acid piperazinoalkyl esters and amides
JPS6264A (en) Amides derived from quinoline, its production and pharmaceutical composition
EP1446399B1 (en) Piperazine derivatives having sst1 antagonistic activity
IE50292B1 (en) Chemical compounds
DE3100575A1 (en) &#34;NEW BENZOESAEURS, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS&#34;
US4018779A (en) Derivatives of 10,11-dihydrobenzo[4,5]cyclohepta[1,2-b]-pyrazolo[4,3-e]pyridine-5(1H)ones
CS236668B2 (en) Manufacturing process of aralkylamides 2-substituted aminophenylalkancarboxyle and amino-3-pyridylalkancarboxyl acides
EP0250361B1 (en) Disubstituted piperazines
JPH0692371B2 (en) Novel heterocyclic derivative, method for producing the same, and method for producing a medicine containing these and particularly useful as an aldose reductase inhibitor
JPH02138266A (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidine dione derivative
US3819630A (en) 3-(1-piperazinylalkyl)-2,4-quinazolinedione compounds and methods for their production
KR840002235B1 (en) Process for preparing carboxylic acid derivatives
BG63336B1 (en) New derivatives of hydrosamic acid, pharmaceutical compositions based on them and method for their preparation
US4022779A (en) Amino derivatives of pyrido(3,4-b)pyrazine carboxylic acids and esters
US4086244A (en) Amidines
US4474783A (en) Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics
Tilley et al. Antagonists of slow-reacting substance of anaphylaxis. 1. Pyrido [2, 1-b] quinazolinecarboxylic acid derivatives
US3898224A (en) 1,6,7,8-Tetrahydro-4-oxo-4H-pyrido {8 1,2-A{9 pyrimidine-9-carboalkoxy compounds
US4260612A (en) Antiallergic nitrogen bridge-head compounds
US4011323A (en) Bi-4-[1-(quinazolinyl-4)piperidyls] and bis{4-[1-(quinazolinyl-4)piperidyl]alkanes}
US4806560A (en) Imidazo[4,5-b]pyridin-2-one derivatives
JPS6130588A (en) Benzo(c)(1,8)naphthylidine, manufacture, use and medicine
US5071849A (en) Dihydropyrimidothiazine derivatives
US4452982A (en) Process for the preparation of nitrogen-bridgehead condensed pyrimidine compounds, and pharmaceutical compositions containing them
HU186675B (en) Process for preparing 2-amino-benzoic acid derivatives

Legal Events

Date Code Title Description
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right